Cocrystal Pharma To Highlight Near-term Clinical Milestones During Presentations At Two Upcoming Investment Conferences
Portfolio Pulse from Benzinga Newsdesk
Cocrystal Pharma, Inc. (NASDAQ:COCP) will present at two investment conferences, highlighting near-term clinical milestones. They plan to report results from their influenza A and norovirus/coronavirus studies in 2024 and 2025.
August 19, 2024 | 8:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cocrystal Pharma is set to present at two investment conferences, focusing on upcoming clinical milestones. They anticipate reporting results from their influenza A and norovirus/coronavirus studies in 2024 and 2025.
The announcement of upcoming presentations at investment conferences and the timeline for clinical study results could generate investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100